Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
NCT ID:
NCT04844112
Eligibility Criteria:
Inclusion Criteria:
* Pathologic or typical imaging based diagnosis of HCC
* Multiphase CT or MRI within 3 months ahead of procedure
* No evidence of distant metastasis
* No contraindications for conventional RFA procedure in our institute, which are uncontrolled coagulopathy (international standard ratio ≥ 1.6, or platelet \> 50,000), poor cooperation, unfeasible for sedation, portal vein tumor thrombus, tumor number \>4, largest tumor size \> 5cm, and tumors abutting portal vein or bile ducts bigger than segmental branches.
Exclusion Criteria:
* Lack of multiphase CT or MRI withing 3 months ahead of procedure
* RFA planned for palliative purpose
* Diagnosed as non-HCC malignancy
* Right hepatectomy state
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
90 Years
Study:
NCT04844112
Study Brief:
Protocol Section:
NCT04844112